Another COVID-19 medicine has hit the market. Drugmaker Hetero on Sunday announced that it had gotten the DGCI nod to launch an antiviral Remdesivir for treatment of COVID-19. The new drug, which is being termed as Covifor, is the second such drug to enter the Indian market after Fabiflu by Glenmark, which came a day earlier. from IndiaTV: Google News Feed https://ift.tt/37Mz4MP
Post a Comment